NASDAQ : CNTB
Connect Biopharma Holdings Limited — Company profile
Healthcare · Biotechnology · United States
Last price 0.8022 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 50.52M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Connect Biopharma Holdings Limited operates as a clinical-stage biopharmaceutical company in the United States. It develops rademikibart, a human monoclonal IgG4 antibody directed against IL-4Rα in two Phase 2 trials for the treatment of acute exacerbations of asthma and chronic obstructive pulmonary disease (COPD). The company was founded in 2012 and is headquartered in San Diego, California.
Details
| Name | Connect Biopharma Holdings Limited |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 64 |
| Founded | 2012 |
| Ipo Date | 2021-03-19 |
| Ceo | Barry Quart |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 17.00 |
| Isin | KYG235491019 |
| Cusip | G23549101 |
| Cik | 1835268 |
| Sic | 2834 |
Key executives
| Name | Title |
|---|---|
| Dr. Barry David Quart Pharm.D. | Chief Executive Officer and Director |
| David L. Szekeres J.D. | President |
| Lisa Peraza CPA | Senior Vice President of Finance |
| Jeff Cohn J.D. | General Counsel and Corporate Secretary |
| Sean T. Ristine | Vice President of Human Resources |
| Dr. Lei Sun Ph.D. | Vice President of Biologics and Head of CMC |
| Dr. Srikanth Pendyala M.D. | Senior Vice President of Clinical Development(Consultant) |
| Kimberly J. Manhard | Executive Vice President and Chief Development Officer |
Contact
| Address | 3580 Carmel Mountain Road, Suite 200, San Diego, California 92130, United States |
| Phone | 877 245 2787 |
| Website | https://www.connectbiopharm.com |